| 摘要 |
Pharmaceutical lysine-based composition to prevent and treat cardiovascular disease comprises: (a) lysine compound(s) chosen from lysine, lysine hydrochloride, lysine dihydrochloride, lysine orotate, lysine succinate and/or lysine glutamate; (b) ascorbate compound(s) chosen from ascorbic acid and/or pharmaceutically acceptable ascorbate salts; and (c) pharmaceutically acceptable carrier. |
